Larimar Therapeutics, Inc. current report, 21 April 2020

Business Context and Reporting Period

This Form 8-K was filed by Zafgen, Inc. (trading symbol: ZFGN) on April 24, 2020, reporting an event that occurred on April 21, 2020. The registrant is a Delaware corporation with principal executive offices in Boston, Massachusetts. The filing addresses a notice received from The Nasdaq Stock Market regarding the company's compliance with listing standards.

Key Financial Metrics

The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The only financial metric disclosed is the stock price performance: the bid price of the Company's common stock closed below the $1.00 per share minimum required for continued listing on the Nasdaq Global Market for 30 consecutive trading days preceding April 21, 2020.

Material Changes and Listing Status

On April 21, 2020, Zafgen, Inc. received a formal Notice from Nasdaq citing non-compliance with Listing Rule 5550(a)(1) due to the sustained low bid price. While the stock continues to trade on the Nasdaq Global Market under the symbol "ZFGN," the company faces potential delisting if compliance is not restored. Nasdaq announced temporary relief from bid price requirements through June 30, 2020, extending the compliance period to expire on December 28, 2020.

Outlook, Risks, and Management Commentary

Management intends to monitor the closing bid price and may consider implementing available options to regain compliance, such as a reverse stock split. The primary risk identified is delisting from the Nasdaq Global Market if the stock price does not close at or above $1.00 for 10 consecutive business days by the end of the Compliance Period. If delisting from the Global Market occurs, the company may transfer to The Nasdaq Capital Market, provided it meets applicable market value requirements, which would afford an additional 180-day compliance period.

Investor Verification Checklist

  • Verify the current closing bid price of ZFGN to assess proximity to the $1.00 threshold.
  • Monitor for any announcements regarding a reverse stock split or other capital structure changes intended to restore compliance.
  • Confirm whether the company meets the market value of publicly held shares requirement for a potential transfer to the Nasdaq Capital Market.
  • Track the expiration of the extended compliance period on December 28, 2020.